Electric Motor Manufacturer YASA Secures £15m Growth Funding, Opens New Oxford Production Facility
YASA, the world’s leading manufacturer of axial-flux electric motors and controllers, today announced raising £15 million in growth funding. Universal Partners joins Parkwalk Advisors and other existing investors in the round, bringing the total raised by the company to £35 million.
This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180131005889/en/
An axial-flux electric motor manufactured by YASA (Photo: Business Wire)
This £15 million investment follows YASA’s signing of long-term development and supply agreements with customers in the automotive sector. The company has recently opened a new 100,000-unit capacity production facility in Oxford, UK to meet the growing demand for its products. Eighty per cent of YASA’s production is destined for export to automotive manufacturers across the world, including China.
The new production facility will be officially opened today by the Secretary of State for Business, Energy and Industrial Strategy, the Rt Hon Greg Clark MP. A range of YASA-powered vehicles will be on display at the event, including cars from Nissan, Jaguar Land Rover and Williams Advanced Engineering.
The Business Secretary Greg Clark MP said, “YASA is a brilliant example of what can be achieved when government, academia and industry come together to turn the best ideas from the best minds into scale-up companies.”
YASA’s innovative axial-flux electric motor design offers best-in-class power and torque densities and is ideally suited to both hybrid and pure electric vehicle applications. With YASA’s technology, automotive manufacturers have greater design flexibility to improve vehicle performance whilst reducing vehicle weight.
YASA motors and controllers enable automotive manufacturers to meet increasingly stringent emissions targets whilst delivering exciting driving experiences. In addition to automotive, YASA motors are used in marine applications and in aerospace where high power density and torque density are critical.
Dr. Chris Harris, YASA’s CEO said, “Our customers are looking to adopt innovative new technologies such as YASA’s axial-flux electric motors and controllers in order to meet the needs of the rapidly expanding hybrid and pure electric automotive market. This additional £15 million in growth funding will enable YASA to further invest in the volume production capacity necessary to meet our customers’ requirements, and to address markets beyond automotive including aerospace and marine.”
Andrew Birrell of Universal Partners - who joins YASA’s board - said, “YASA has unique and highly differentiated axial-flux motor technology that offers clear advantages in terms of power and torque density compared to their competition in class. We are pleased to have the opportunity to invest and are very excited by the prospects for the Company.”
Alastair Kilgour, Chief Investment Officer at Parkwalk Advisors said, “YASA has made excellent commercial progress over the past two years and we are pleased to continue to support the Company in this latest financing round. With the rapid growth of electrification in automotive and other sectors such as aerospace and marine, we believe YASA has huge business potential.”
<ends>
EDITOR’S NOTES
YASA http://www.yasa.com/
YASA is the world’s leading manufacturer of axial-flux electric motors and controllers for automotive, aerospace and marine applications. YASA’s proprietary electric motor and controller products offer the smallest, lightest form factor for a given power and torque requirement. The privately-held company is based in Oxford, the UK’s automotive manufacturing heartland. Investors include Parkwalk Advisors and Universal Partners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180131005889/en/
Contact information
For all media enquiries, contact:
Tamara Sword
TRM&C
tamara@trmandc.co.uk
+44
(0)7906 638351
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
You Up? Grindr’s “Right Now” Goes Global30.5.2025 16:00:00 EEST | Press release
Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded people without wasting time on mismatched expectations. The response to our initial March launc
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 15:00:00 EEST | Press release
Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative financing approaches to manage the costs of treatment and care. “Despite CAR T-cell therapy being available in the United States for nearly seven years in large B-cell lymphoma, only approximately two out of 10 eligible patients with some advanced blood cancers ever receive CAR T-cell therapy,” said Miguel Perale
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 12:17:00 EEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
FDA Grants De Novo Clearance for Reflow Medical's Spur ® Peripheral Retrievable Stent System30.5.2025 07:08:00 EEST | Press release
Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the company’s Spur Peripheral Retrievable Stent System, a unique clinical solution for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529610368/en/ The first and only retrievable stent system that features a self-expanding stent with an integrated dilatation balloon catheter on an over-the-wire system. It is designed for controlled lesion penetration and treatment through a series of radially expandable spikes. Known as Retrievable Scaffold Therapy (RST), the spikes on the Spur Stent penetrate the lesion to increase the acute luminal diameter and modify the lesion morphology to change vessel complia
Black Forest Labs Launches FLUX.1 Kontext, a Breakthrough in Context-aware Image Generation and Editing29.5.2025 23:27:00 EEST | Press release
Black Forest Labs, Europe’s fast-rising frontier AI research lab, announced today the release of FLUX.1 Kontext, a new suite of image generation models that introduce powerful in-context generating and editing capabilities. Kontext enables users to generate, retouch, and iteratively refine images from both text and visual inputs, without the need for finetuning or complex editing workflows. FLUX.1 Kontext is designed for creators, developers, and enterprises seeking precision and creative control. The model can understand and extract visual concepts from images, maintain stylistic and character consistency across multiple scenes, and apply localized edits with exceptional fidelity. This enables seamless visual storytelling, fast ideation, and highly targeted content generation, all at inference speeds up to 8x faster than leading alternatives. "FLUX.1 Kontext represents a fundamental shift from traditional editing approaches by unifying image generation and editing in a single flow mat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom